1. Home
  2. GROV vs TELA Comparison

GROV vs TELA Comparison

Compare GROV & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grove Collaborative Holdings Inc.

GROV

Grove Collaborative Holdings Inc.

HOLD

Current Price

$1.19

Market Cap

50.4M

ML Signal

HOLD

Logo TELA Bio Inc.

TELA

TELA Bio Inc.

N/A

Current Price

$0.86

Market Cap

41.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GROV
TELA
Founded
2016
2012
Country
United States
United States
Employees
295
N/A
Industry
Package Goods/Cosmetics
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.4M
41.3M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
GROV
TELA
Price
$1.19
$0.86
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$1.60
$2.00
AVG Volume (30 Days)
56.8K
85.2K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
37.59
EPS
N/A
N/A
Revenue
N/A
$80,275,000.00
Revenue This Year
N/A
$10.23
Revenue Next Year
$6.81
$14.26
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.84
52 Week Low
$1.03
$0.50
52 Week High
$1.60
$2.19

Technical Indicators

Market Signals
Indicator
GROV
TELA
Relative Strength Index (RSI) 48.52 47.64
Support Level $1.10 $0.79
Resistance Level $1.47 $0.94
Average True Range (ATR) 0.08 0.09
MACD 0.00 -0.01
Stochastic Oscillator 72.10 30.59

Price Performance

Historical Comparison
GROV
TELA

About GROV Grove Collaborative Holdings Inc.

Grove Collaborative Holdings Inc is a digital-first, sustainability-oriented consumer products innovator specializing in the development and sale of household, personal care, beauty and other consumer products with a human and environmental focus. The Company sells its products through a direct-to-consumer (DTC) platform and the Company's mobile applications, where the Company sells products from Grove-owned brands (Grove Brands) and third-parties.

About TELA TELA Bio Inc.

TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

Share on Social Networks: